• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬太尼给药形式选择背后的理由:丹麦全科医生的德尔菲调查

Rationales behind the choice of administration form with fentanyl: Delphi survey among Danish general practitioners.

作者信息

Jacobsen Ramune, Møldrup Claus, Christrup Lona

机构信息

Section for Health Services Research, Department of Public Health, Faculty of Health Sciences, University of Copenhagen, Denmark.

出版信息

J Opioid Manag. 2010 Jul-Aug;6(4):259-68. doi: 10.5055/jom.2010.0024.

DOI:10.5055/jom.2010.0024
PMID:20862906
Abstract

BACKGROUND AND AIM

The aim of this study was to describe the rationale behind the choice of fentanyl administration forms among Danish general practitioners (GPs).

METHODS

Thirty-eight Danish GPs were contacted via an Internet survey system to perform a Delphi survey. In the brainstorming phase, the main reasons for prescribing and not prescribing fentanyl patches, oral transmucosal systems (OTFCs), and nasal sprays were identified. In the second phase, GPs were asked to rate the importance of each reason.

RESULTS AND DISCUSSION

Thirty-three GPs responded in the brainstorming phase, and 33 and 31 in two rating rounds, respectively. The most important reason to choose fentanyl patches was that patients' clinical condition did not allow them to take analgesia orally. OTFCs were primarily seen as a self-administrative alternative to injections in case of breakthrough pain. The main reasons for not choosing OTFCs were intolerance to fentanyl and price. The most important possible rationale to choose fentanyl nasal spray was easy administration. The most important possible reasons to not choose fenanyl nasal spray were application side effects.

CONCLUSIONS

The rationale behind the choice of administration form with fentanyl partly differed from those overviewed in the literature. Fentanyl nasal spray was seen as a better option for treatment of breakthrough pain among terminally ill patients if compared with OTFCs.

摘要

背景与目的

本研究旨在描述丹麦全科医生选择芬太尼给药形式背后的基本原理。

方法

通过互联网调查系统联系了38名丹麦全科医生以进行德尔菲调查。在头脑风暴阶段,确定了开具和不开具芬太尼透皮贴剂、口腔黏膜给药系统(OTFC)和鼻喷雾剂的主要原因。在第二阶段,要求全科医生对每个原因的重要性进行评分。

结果与讨论

在头脑风暴阶段有33名全科医生做出回应,在两轮评分中分别有33名和31名做出回应。选择芬太尼透皮贴剂的最重要原因是患者的临床状况不允许他们口服镇痛药。OTFC主要被视为在爆发性疼痛情况下替代注射的一种自我给药方式。不选择OTFC的主要原因是对芬太尼不耐受和价格因素。选择芬太尼鼻喷雾剂的最重要可能理由是给药方便。不选择芬太尼鼻喷雾剂的最重要可能原因是应用时的副作用。

结论

芬太尼给药形式选择背后的基本原理与文献中概述的部分不同。与OTFC相比,芬太尼鼻喷雾剂被视为治疗晚期患者爆发性疼痛的更好选择。

相似文献

1
Rationales behind the choice of administration form with fentanyl: Delphi survey among Danish general practitioners.芬太尼给药形式选择背后的理由:丹麦全科医生的德尔菲调查
J Opioid Manag. 2010 Jul-Aug;6(4):259-68. doi: 10.5055/jom.2010.0024.
2
Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.丹麦疼痛专家选择芬太尼透皮贴剂和口腔黏膜系统的理由——一项德尔菲研究。
Pain Med. 2009 Nov;10(8):1442-51. doi: 10.1111/j.1526-4637.2009.00724.x. Epub 2009 Sep 29.
3
Clinical rationale for administering fentanyl to cancer pain patients: two Delphi surveys of pain management experts in Denmark.给癌症疼痛患者使用芬太尼的临床依据:对丹麦疼痛管理专家进行的两项德尔菲调查。
J Opioid Manag. 2008 Nov-Dec;4(6):383-91. doi: 10.5055/jom.2008.0042.
4
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs.芬太尼在缓解爆发性癌痛中的作用:不同的生物技术,不同的结果,不同的药物成本。
J Oncol Pharm Pract. 2021 Mar;27(2):445-447. doi: 10.1177/1078155220983429. Epub 2020 Dec 26.
5
Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.鼻腔内芬太尼喷雾:一种用于治疗突破性癌痛的新型剂型。
Ann Pharmacother. 2012 Oct;46(10):1382-91. doi: 10.1345/aph.1R069. Epub 2012 Sep 25.
6
Physicians' knowledge of transdermal fentanyl.
Palliat Med. 2005 Jan;19(1):9-16. doi: 10.1191/0269216305pm971oa.
7
[Transmucosal fentanyl administration: sublingual, buccal, nasal - all the same? Treatment of breakthrough cancer pain].[经黏膜给予芬太尼:舌下、颊部、鼻腔给药——效果相同吗?癌痛爆发痛的治疗]
MMW Fortschr Med. 2017 Oct;159(Suppl 6):15-22. doi: 10.1007/s15006-017-0081-1. Epub 2017 Oct 5.
8
Fentanyl nasal spray (Lazanda) for pain.用于止痛的芬太尼鼻喷雾剂(拉赞达)。
Med Lett Drugs Ther. 2011 Dec 12;53(1379-1380):99-100.
9
Fentanyl nasal spray for the treatment of cancer pain.芬太尼鼻喷剂治疗癌症疼痛。
Expert Opin Pharmacother. 2011 Jul;12(10):1653-9. doi: 10.1517/14656566.2011.585637. Epub 2011 May 24.
10
Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain.芬太尼果胶鼻腔喷雾剂:一种治疗爆发性癌痛的新型鼻腔给药方法。
Expert Rev Clin Pharmacol. 2013 Jan;6(1):9-22. doi: 10.1586/ecp.12.69.

引用本文的文献

1
Fentanyl Formulations in the Management of Pain: An Update.芬太尼制剂在疼痛管理中的应用:更新。
Drugs. 2017 May;77(7):747-763. doi: 10.1007/s40265-017-0727-z.
2
A comprehensive review of rapid-onset opioids for breakthrough pain.快速起效类阿片药物治疗爆发性疼痛的全面综述。
CNS Drugs. 2012 Jun 1;26(6):509-35. doi: 10.2165/11630580-000000000-00000.